Showing results (111-120 of 136) with videos related to
Sort By:
Pageof 14
Biological Trace Element Research|August 9, 2019
Effects of Zinc Acetate on Serum Zinc Concentrations in Chronic Liver Diseases: a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial and a Dose Adjustment TrialKazuhiro Katayama, Atsushi Hosui, Yoshiyuki Sakai, et al.Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|November 7, 2009
[An operated case of retroperitoneal venous hemangioma complicated with Kasabach-Merritt syndrome which was well controlled by danaparoid sodium]Aya Moriguchi, Kiyoshi Iwahashi, Yoshiki Onishi, et al.Liver Cancer|December 14, 2017
Prospective Comparison of Gd-EOB-DTPA-Enhanced MRI with Dynamic CT for Detecting Recurrence of HCC after Radiofrequency AblationYasuharu Imai, Kazuhiro Katayama, Masatoshi Hori, et al.Oncogene|February 24, 2025
Cyclin E1 overexpression sensitizes ovarian cancer cells to WEE1 and PLK1 inhibitionQian Xi, Akiko Kunita, Miho Ogawa, et al.Journal of Gastroenterology|October 19, 2006
Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis CTsugiko Oze, Naoki Hiramatsu, Nao Kurashige, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 27, 2019
Hypozincemia is associated with human hepatocarcinogenesis in hepatitis C virus-related liver cirrhosisRyuta Shigefuku, Motoh Iwasa, Kazuhiro Katayama, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 24, 2007
Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudineNao Kurashige, Naoki Hiramatsu, Kazuyoshi Ohkawa, et al.Journal of Gastroenterology|August 23, 2011
Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels: a matched case-control studyNaoki Hiramatsu, Yuko Inoue, Tsugiko Oze, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 19, 2004
The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in JapanNaoki Hiramatsu, Akinori Kasahara, Fumihiko Nakanishi, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 9, 2006
Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?Naoki Hiramatsu, Tsugiko Oze, Natsuko Tsuda, et al.Pageof 14